Moderna Inc. (NASDAQ:MRNA)

The financial trajectory from 2019 to 2023 exhibits extreme volatility, characterized by an initial period of operational losses, a sudden and massive surge in profitability, and a subsequent return to a deficit position.

Initial Operating Deficits (2019-2020)

During the 2019 and 2020 fiscal years, a consistent trend of negative earnings was observed. EBITDA decreased from -477 million US$ in 2019 to -703 million US$ in 2020, reflecting an widening operational deficit that aligned with the decline in net income from -514 million US$ to -747 million US$.

Peak Profitability Phase (2021-2022)

A dramatic reversal in financial performance occurred in 2021, with EBITDA surging to 13,535 million US$. Although profitability remained substantial in 2022 with an EBITDA of 9,952 million US$, a downward trend began to emerge, marking a contraction of approximately 26% relative to the 2021 peak.

Return to Negative Earnings (2023)

The 2023 fiscal year indicates a complete reversal of the prior gains, with EBITDA falling to -3,283 million US$. This return to a loss position is more severe than the deficits recorded in 2019 and 2020, with net income dropping to -4,714 million US$.

Earnings Metric Correlation

A high degree of correlation is observed across net income, EBT, EBIT, and EBITDA. EBITDA consistently represents the most favorable figure in each period, confirming that depreciation and amortization provided a consistent positive adjustment to the operating results. The magnitude of the swing between 2020 and 2021 represents the most significant variance in the analyzed period, with an EBITDA increase of over 14 billion US$.

The financial trajectory between 2019 and 2023 is characterized by extreme volatility in both valuation and operational earnings. Enterprise value experienced a rapid expansion, peaking in 2020 before entering a consistent multi-year period of contraction.

Enterprise Value Trends

A substantial increase is observed from 2019 to 2020, with the value rising from 8,579 million to 57,415 million. Following this peak, a downward trend occurred over the subsequent three years, resulting in a value of 28,826 million by December 31, 2023.

EBITDA Performance

Operational earnings transitioned from losses in 2019 and 2020 to a significant peak of 13,535 million in 2021. While profitability remained positive in 2022 at 9,952 million, a return to a deficit was recorded in 2023, with EBITDA falling to -3,283 million.

EV/EBITDA Ratio Analysis

The ratio was only applicable during the years of positive EBITDA. Between 2021 and 2022, the ratio increased from 3.77 to 4.52, suggesting that the contraction in EBITDA was more pronounced than the decrease in enterprise value during that period. The ratio became unavailable in 2023 due to the return to negative earnings.